ISRCTN42303887进行中（未招募）未知
IMAGINE: Integrating Medically Actionable Genomics INto Early-phase trials
Greater Glasgow & Clyde NHS Board0 个研究点目标入组 200 人开始时间: 2020年1月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult patients aged 18 years or over
- •2. Patients referred for an early-phase clinical trial with histologically confirmed advanced solid tumours
- •3. Patient meets one of the following criteria:
- •3.1. Willing and fit to have a tumour biopsy aimed at obtaining sufficient tissue for molecular profiling
- •3.2. Not willing/fit to have a tumour biopsy and had prior tumour molecular profiling
- •4. Patient deemed a suitable candidate for further systemic anti-cancer therapy
- •5. Willing and able to provide signed informed consent
排除标准
- •Does not meet the inclusion criteria
研究者
相似试验
终止
不适用
The use of non invasive methods to predict drug handling and toxicity of SunitinibMetastatic renal cell carcinoma (RCC)Metastatic Gastrointestinal Stromal Tumuor (GIST)Cancer - KidneyCancer - Other cancer typesACTRN12610000897066Peter MacCallum Cancer Centre70
终止
不适用
The use of non invasive methods to predict drug handling and toxicity of Irinotecaocally advanced, recurrent or metastatic colorectal adenocarcinomaLocally advanced, recurrent or metastatic colorectal adenocarcinomaCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12610000898055Peter MacCallum Cancer Centre70
撤回
不适用
Bringing Neuroimaging and Genetics to the Clinic: A case for Attention-Deficit/Hyperactivity Disorder and Autism Spectrum DisorderAttention-Deficit/Hyperactivity DisorderDisorder 2) ASDAutisme Spectrum DisorderDisorder 1) ADHD10009841NL-OMON44585Radboud Universitair Medisch Centrum1,125
招募中
不适用
Newborn Genomics ProgrammeGenetic DiseaseNewborn MorbidityNCT06081075Liggins Institute500
Unknown
不适用
Epigenomic and Machine Learning Models to Predict Pancreatic CancerPancreatic CancerNCT06334458European Institute of Oncology170